Tingling or numbness in your hands and feet during lymphoma treatment is often chemo-induced peripheral neuropathy. This guide explains why it happens, what to watch for, and how CION's team protects your nerves while treating the lymphoma.
If you have noticed numbness, tingling, or a "pins-and-needles" feeling in your fingers and toes during treatment for lymphoma, you may be experiencing chemotherapy-induced peripheral neuropathy — often shortened to CIPN. It is one of the more common and better-recognised side effects of certain lymphoma chemotherapy drugs, and it is a frequent reason people search for "numbness tingling after chemo".
Peripheral neuropathy means damage to the peripheral nerves — the network of nerves that carry sensation and movement signals between your hands, feet and the rest of your body. Some chemotherapy drug classes are toxic to these nerves, particularly the long sensory fibres that reach your fingertips and toes. Because those are the longest nerves, symptoms usually start there and can slowly move up the hands and feet in a "glove and stocking" pattern.
The reassuring part: for most people the numbness and tingling are manageable and improve over time once treatment is adjusted or finished. The important part: telling your team early is the single best thing you can do to protect your nerves. This guide covers the symptoms, the causes, what CION does about it, and recovery. For the wider picture of side-effect care, see managing lymphoma chemotherapy side effects.
Chemotherapy-induced peripheral neuropathy is common — published reviews report that around a third or more of patients treated with nerve-affecting chemotherapy agents develop some degree of peripheral neuropathy, with the risk rising as the total dose increases. Reporting numbness and tingling early lets the oncologist adjust the dose — the one measure shown to limit lasting nerve damage. (Source: chemotherapy-induced peripheral neuropathy incidence data summarised in ASCO and ESMO supportive-care guidelines. Figures vary by drug and by individual.)
Peripheral neuropathy from lymphoma chemotherapy is mostly sensory — it affects feeling more than strength, at least at first. Symptoms usually appear symmetrically in both hands and both feet.
A reduced or absent sense of touch in the fingertips and toes — clothes buttons, coins or a phone screen can feel harder to manage, and the floor may feel oddly distant underfoot.
A prickling, "fizzy" or crawling sensation in the hands and feet — the classic tingling after chemo that many people describe first. It can come and go or be constant.
Some people feel a burning, aching or electric-shock type pain. Skin may become sensitive to light touch or to cold — even a cold surface or breeze can feel sharp.
Reduced feeling can make balance less steady and fine tasks — writing, fastening a button, feeling for the car pedals — more difficult. This is why fall-prevention advice matters.
Symptoms and severity vary by individual and by the drug used. Any new or worsening numbness, tingling or weakness should be reported to your team promptly.
Chemo-induced neuropathy sits at the meeting point of effective lymphoma treatment and quality of life. Managing it well means neither ignoring the symptoms nor undertreating the lymphoma. CION's approach is built around that balance:
If numbness or tingling is affecting your daily life, our specialists at the best lymphoma hospital in Hyderabad can review your symptoms and plan. Book a free consultation to talk it through.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
If nerve symptoms are affecting you during or after lymphoma treatment, CION's team can review them, adjust your plan where needed, and support your recovery.
Not every lymphoma drug causes neuropathy, but a few well-recognised drug classes do. Rather than name specific medicines here — regimen-specific questions are best answered on our Lymphoma Treatment in Hyderabad page — it helps to understand the mechanism:
Some people are more susceptible — for example if they already have nerve strain from diabetes, heavy alcohol use, or a pre-existing neuropathy. Your oncologist takes these factors into account when planning treatment and monitoring you.
There is no single test that "cures" chemo-induced neuropathy, so good management is about vigilance, timely adjustment and practical symptom relief. CION delivers this care directly.
At each cycle your team asks specific questions — about numbness, tingling, pain, balance, and everyday tasks like buttoning a shirt or feeling the floor — and examines your reflexes and sensation. This structured screening catches early changes so action can be taken before nerve damage becomes fixed.
If neuropathy develops, adjusting the chemotherapy dose or spacing out the schedule is the most effective step — and, per NCCN and ESMO guidance, essentially the only measure proven to limit further nerve damage. Your oncologist balances this against maintaining effective control of the lymphoma, and will explain the trade-off clearly.
For nerve pain, doctors may prescribe medicines from specific nerve-pain drug classes (chosen for you individually). Physiotherapy helps balance and strength, and occupational therapy supports hand function and daily activities. Foot care, skin protection and fall-prevention advice reduce the risk of injury while feeling is reduced.
Both ESMO and ASCO advise against unproven supplements to prevent CIPN, because none has been shown to work reliably. CION follows this evidence rather than selling remedies that may raise false hope.
For the majority of people, chemo-induced neuropathy improves after treatment finishes, though the timeline is slow. Peripheral nerves regenerate gradually, so numbness and tingling often ease over months — sometimes up to a year or more. Milder neuropathy usually recovers more completely than severe neuropathy, which is another reason early reporting and timely dose adjustment matter so much.
A minority of survivors have some lasting numbness or tingling. If that happens, the focus shifts to living well with the symptoms: physiotherapy to keep balance and strength, occupational-therapy strategies for daily tasks, nerve-pain treatment where needed, and practical safety measures. Our late-effects clinic monitors nerve symptoms as part of overall survivorship care.
Neuropathy is one of several things people manage on the road back to normal life. You may also find these helpful:
Remember that different survivorship issues affect different people — some also plan around the risk of second cancers or infection risk during treatment. Our team can point you to the right support.
Reporting numbness or tingling early is not "making a fuss" — it is clinically important. Because dose adjustment is the main proven way to prevent lasting nerve damage, the sooner your team knows, the more they can protect your nerves while still treating the lymphoma effectively. If symptoms affect your balance, walking, or ability to grip, or if they worsen quickly, contact your team the same day. (Source: ASCO and ESMO supportive-care guidance on chemotherapy-induced peripheral neuropathy.)
Numbness and tingling deserve attention, and a specialist review is especially valuable if:
CION offers a dedicated, free written second-opinion service from our lymphoma specialists. You deserve a plan built around healing and quality of life. Request your free second opinion or call 18002028726. Caregivers supporting someone through treatment may also find our caregiver's guide to lymphoma useful.
Get a free written second opinion from CION's lymphoma team — especially valuable if your nerve symptoms haven't been reviewed or your dose hasn't been adjusted.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Chemotherapy-induced peripheral neuropathy (CIPN) is nerve damage caused by certain chemotherapy drugs used to treat lymphoma. It most often affects the small sensory nerves in the hands and feet, causing numbness, tingling, pins-and-needles or burning — usually in a "glove and stocking" pattern. Some drug classes used against lymphoma, particularly the vinca-alkaloid and certain antibody-drug conjugate groups, are more likely to cause it. Symptoms typically build up gradually over several cycles and often start in the toes and fingertips. In most people the nerves recover slowly once treatment finishes, though this can take months, and a minority have longer-lasting symptoms. Tell your CION team early — dose adjustments can protect your nerves.
Numbness and tingling after chemo happen because some lymphoma drugs are toxic to peripheral nerves — the long nerve fibres that carry sensation between your hands, feet and spinal cord. These drugs can interfere with the nerve's internal transport system or its protective coating, so signals become faulty. The result is peripheral neuropathy: tingling, numbness, a "pins and needles" feeling, or sensitivity to cold or touch. Because the longest nerves are affected first, symptoms usually begin in the toes and fingertips and can spread upward. The risk rises with higher cumulative doses. Always report new numbness or tingling promptly — it is one of the most important reasons a doctor may adjust your chemotherapy dose or schedule.
For most people it is not permanent. Once the responsible chemotherapy is stopped or reduced, the peripheral nerves usually begin to recover, though this happens slowly — often over several months to a year or more. Milder neuropathy tends to resolve more completely than severe neuropathy. A minority of patients do have some lasting numbness or tingling, particularly if symptoms were severe during treatment. This is exactly why early reporting matters: catching neuropathy early lets your CION oncologist adjust the dose before nerve damage becomes fixed. Our late-effects clinic monitors nerve symptoms during survivorship and supports recovery.
Management starts with careful monitoring at every cycle: your team asks about numbness, tingling, balance and buttoning clothes, and examines your reflexes and sensation. If neuropathy develops, the most effective step is adjusting the chemotherapy dose or schedule — the single proven way to limit further nerve damage. For symptom relief, doctors may use certain nerve-pain medicines (prescribed by class, not brand), physiotherapy, and occupational therapy for hand function and balance. Per ESMO and ASCO guidance, no supplement reliably prevents CIPN, so we avoid unproven remedies. Fall-prevention advice, foot care and skin protection are also part of the plan. Discuss regimen-specific questions on our Lymphoma Treatment page.
Report any new numbness, tingling, burning or weakness as soon as you notice it — do not wait until your next scheduled visit. Call sooner if the symptoms are spreading, getting worse quickly, affecting your balance or walking, making it hard to feel the floor or fasten buttons, or if you develop weakness, difficulty gripping, or new problems with bladder or bowel control. Sudden severe symptoms always warrant an urgent call. Early reporting lets your oncologist adjust treatment before nerve damage becomes lasting. You can reach CION's team on 1800 202 8726 or book a consultation to review your symptoms.
There is no medicine or supplement that reliably prevents chemo-induced neuropathy — both ESMO and ASCO advise against using unproven agents for prevention. The most effective protection is close monitoring plus prompt dose adjustment when early symptoms appear, which is built into CION's treatment protocols. Simple measures help too: report symptoms early, protect your hands and feet from injury and extreme cold, keep active to maintain balance and circulation, and manage other conditions such as diabetes that can add to nerve strain. Your team weighs the small risk of neuropathy against the benefit of full-dose therapy for controlling the lymphoma. Learn more about managing lymphoma chemotherapy side effects.
No. Neuropathy is a side effect of certain drugs, not a sign of whether the lymphoma is responding. Response is measured by scans (such as PET-CT), blood tests and physical examination — not by side effects. Some people with an excellent response to treatment develop neuropathy, and some with little neuropathy still respond very well. If numbness or tingling appears, it simply means the drug is affecting your nerves and the dose may need adjusting; it does not mean treatment should stop or that it has failed. Your CION oncologist balances effective disease control with protecting your nerves, and will explain how your response is being tracked. For treatment-effectiveness questions, see our Lymphoma Treatment in Hyderabad page.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.